Lorviqua

Medicinal product

(Invented) name

Lorviqua

Active substance (s)

Lorlatinibas

Strength

25 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L01ED05, Lorlatinib

Marketing authorisation holder

Pfizer Europe MA EEIG, Belgija

Date of authorisation

2019-05-06

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Film-coated tablet	1 vnt.
Lorlatinibas	25 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
101610	87714	1087714	lizdinė plokštelė	N120		Receptinis	EU/1/19/1355/001	Netiekiama	-	-	No	-	-
104225	90329	1090329	lizdinė plokštelė	N90		Receptinis	EU/1/19/1355/003	Tiekiama	2025-05-26	-	No	-	-

Stadijos

Data	Stadija
2019-05-06	Registruotas